Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171777 | SCV000055226 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Invitae | RCV000204048 | SCV000259852 | benign | Long QT syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619217 | SCV000736314 | benign | Cardiovascular phenotype | 2016-09-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Advanced Laboratory Medicine, |
RCV000853012 | SCV000995769 | benign | Primary dilated cardiomyopathy | 2018-02-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001557217 | SCV001778938 | likely benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253265 | SCV002524817 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000171777 | SCV002555686 | likely benign | not specified | 2022-06-06 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000171777 | SCV001922355 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000171777 | SCV001930321 | benign | not specified | no assertion criteria provided | clinical testing |